Hjem › Juvenil artritt › New York
Kliniske studier for Juvenil artritt i New York
5 studier for Juvenil artritt søker deltakere på steder i New York.
Byer i New York
Offisiell studietekst (engelsk)
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
- Col Uni Med Center New York Presby, New York
RekruttererFase 1
Alder 2 til 17 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06751238Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
- Boston Childrens Health Physicians /ID# 253437, Valhalla
RekruttererFase 3
Alder 1 til 17 · Alle kjønn · Oppdatert 15. sep. 2026 · NCT05609630A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- Columbia University Medical Center /ID# 262587, New York
- Boston Childrens Health Physicians /ID# 258061, Valhalla
RekruttererFase 3
Alder 5 til 17 · Alle kjønn · Oppdatert 1. sep. 2026 · NCT06100744Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Albany Medical College, Albany
- Cohen Children's Medical Center of New York, Lake Success
- Hospital for Special Surgery, New York
- og 3 flere
RekruttererObservasjonsstudie
Opp til 21 år · Alle kjønn · Oppdatert 27. aug. 2026 · NCT02418442Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
- NYU Langone Health, New York
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 9. jul. 2026 · NCT07138898Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.